sdbanks

Dendreon 2007 Annual Report and How Provenge Will Propel Company

When you mention "....committee passed Provenge with a 17-0 annonymous vote and deemed Provenge "Reasonably safe....".

You should balance it with that the drug was not approved at that time and has since dropped back from $25.00 - $3.50.

It's newest trial has just finished and results are expected within 90 days ( April??).